-
EP1158004
European procedure
Extract from the Register of European Patents
EP About this file: EP1158004
| EP1158004 - Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 13.05.2011 Database last updated on 26.06.2024 | Most recent event Tooltip | 27.09.2013 | Lapse of the patent in a contracting state | published on 30.10.2013 [2013/44] | Applicant(s) | For all designated states Japan Tobacco Inc. 2-1, Toranomon 2-chome, Minato-ku Tokyo 105-8422 / JP | [2010/27] |
| Former [2001/48] | For all designated states Japan Tobacco Inc. 2-1, Toranomon 2-chome, Minato-ku Tokyo 105-8422 / JP | Inventor(s) | 01 /
Takashi, Tsuji 3-198, Edogawadaihigashi Nagareyama-shi, Chiba 270-0111 / JP | 02 /
Katsunari, Tezuka c/o Pharmaceutical Frontier Res. Lab Japan Tobacco, Inc., 1-13-2, Fukuura, Kanazawa-ku Yokohama-shi, Kanagawa 236-0004 / JP | 03 /
Nobuaki, Hori c/o Pharmaceutical Frontier Res. Lab Japan Tobacco, Inc., 1-13-2, Fukuura, Kanazawa-ku Yokohama-shi, Kanagawa 236-0004 / JP | [2010/16] |
| Former [2001/48] | 01 /
Takashi, Tsuji 3-198, Edogawadaihigashi Nagareyama-shi, Chiba 270-0111 / JP | ||
| 02 /
Katsunari, Tezuka, Pharmaceutical Frontier Res.Lab Japan Tobacco, Inc., 1-13-2, Fukuura, Kanazawa-ku Yokohama-shi, Kanagawa 236-0004 / JP | |||
| 03 /
Nobuaki, Hori 1-13-2, Fukuura, Kanazawa-ku Yokohama-shi, Kanagawa 236-0004 / JP | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
| Former [2001/48] | VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE | Application number, filing date | 01111930.2 | 18.05.2001 | [2001/48] | Priority number, date | JP20000147116 | 18.05.2000 Original published format: JP 2000147116 | JP20010099508 | 30.03.2001 Original published format: JP 2001099508 | [2001/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1158004 | Date: | 28.11.2001 | Language: | EN | [2001/48] | Type: | A3 Search report | No.: | EP1158004 | Date: | 24.07.2002 | [2002/30] | Type: | B1 Patent specification | No.: | EP1158004 | Date: | 07.07.2010 | Language: | EN | [2010/27] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.06.2002 | Classification | IPC: | C07K16/28, A61K39/395, C12N15/13, C12N15/11, G01N33/543, C12N5/20 | [2001/48] | CPC: |
C07K16/18 (EP,KR,US);
A61P13/12 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
C07K16/28 (EP,US);
C07K16/2818 (EP,US);
A01K2217/05 (EP,US);
A61K2039/505 (EP,US);
C07K2317/21 (EP,US);
C07K2317/56 (EP,US);
C07K2317/73 (EP,US);
C07K2317/732 (EP,US);
C07K2317/76 (EP,US);
C07K2317/92 (EP,US);
C07K2319/00 (EP,US);
C07K2319/30 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2001/48] | Title | German: | Humane monoklonale Antikörper gegen das kostimulatorische Signaltransduktionsmolekül AILIM und pharmazeutische Verwendungen davon | [2001/48] | English: | Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof | [2001/48] | French: | Anticorps monoclonal humain dirigé contre la molécule de co-stimulation de transduction du signal AILIM et leur utilisation pharmaceutique | [2009/48] |
| Former [2001/48] | Anticorps monoclonal humain dirige contre la molécule de co-stimulation de transduction du signal AILIM et LEUR UTILISATION PHARMACEUTIQUE | Examination procedure | 13.06.2001 | Examination requested [2001/48] | 08.11.2006 | Despatch of a communication from the examining division (Time limit: M04) | 16.03.2007 | Reply to a communication from the examining division | 21.09.2007 | Despatch of a communication from the examining division (Time limit: M04) | 25.01.2008 | Reply to a communication from the examining division | 17.07.2008 | Despatch of a communication from the examining division (Time limit: M04) | 19.11.2008 | Reply to a communication from the examining division | 28.10.2009 | Communication of intention to grant the patent | 05.03.2010 | Fee for grant paid | 05.03.2010 | Fee for publishing/printing paid | Divisional application(s) | EP10158665.9 / EP2216343 | EP10182520.6 / EP2295467 | Opposition(s) | 08.04.2011 | No opposition filed within time limit [2011/24] | Fees paid | Renewal fee | 30.05.2003 | Renewal fee patent year 03 | 28.05.2004 | Renewal fee patent year 04 | 31.05.2005 | Renewal fee patent year 05 | 31.05.2006 | Renewal fee patent year 06 | 31.05.2007 | Renewal fee patent year 07 | 20.03.2008 | Renewal fee patent year 08 | 25.05.2009 | Renewal fee patent year 09 | 25.05.2010 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | TR | 07.07.2010 | [2013/44] | Documents cited: | Search | [Y]WO9915553 (BUNDESREPUBLIK DEUTSCHLAND LET [DE], et al) [Y] 1-9,15-90,95-102 * abstract * * page 1, lines 5-24 * * page 2, lines 1-19 * * page 4, lines 29,30 * * page 5, lines 10-19 * * page 7, lines 20-34 * * page 9, lines 23,24 * * page 12, lines 6-26 *; | [Y]EP0984023 (JAPAN TOBACCO INC [JP]) [Y] 1-102 * abstract * * page 2, lines 54-58 * * page 4, lines 45,46 * * page 7, lines 38,39 * * page 8, lines 6-27 * * page 18, lines 51-58 * * page 21, line 53 - page 22, line 7 * * page 23, lines 12,18 * * page 32, line 55 - page 33, line 16 * * page 33, line 41 - page 36, line 19 * * page 37, lines 45-57 * * page 38, lines 7-29 *; | [PY]WO0046240 (AMGEN INC [US], et al) [PY] 1-9,15-90,95-102 * abstract * * page 1, lines 4-11 * * page 3, line 31 * * page 7, lines 9-16 * * page 8, lines 3-17 * * page 10, line 17 * * page 14, line 32 * * page 20, lines 4-7 * * page 49, line 21 - page 50, line 33 * * page 51, lines 25,26 * * page 52, lines 1-12 * * page 65, lines 16,17 *; | [E]EP1125585 (JAPAN TOBACCO INC [JP]) [E] 1-9,15-90,95-102 * abstract * * column 1, lines 12-18 * * column 8, line 56 - column 9, line 37 * * column 9, line 56 - column 10, line 2 * * column 10, line 41 - column 11, line 1 * * column 11, lines 26-45 * * column 11, line 56 - column 12, line 19 * * column 17, line 26 - column 19, line 51 * * column 22, lines 35,36 * * column 23, lines 7-10 * * column 27, line 50 - column 28, line 16 * * column 49, lines 7-19 * * column 62, lines 39-52 *; | [Y] - MCADAM ALEXANDER ET AL, "Mouse inducible costimulatory (ICOS) molecule expression is increased by CD28 costimulation and regulates development of Th2 cells.", FASEB JOURNAL, Joint Annual Meeting of the American Association of Immunologists and the Clinical Immunology Society;Seattle, Washington, USA; May 12-16, 2000, (20000420), vol. 14, no. 6, ISSN 0892-6638, page A1169, XP001037459 [Y] 1-9,15-90,95-102 * abstract * | [Y] - TAMATANI TAKUYA ET AL, "AILIM/ICOS: A novel lymphocyte adhesion molecule.", INTERNATIONAL IMMUNOLOGY, (200001), vol. 12, no. 1, ISSN 0953-8178, pages 51 - 55, XP001007236 [Y] 1-102 * abstract * * page 51, column 1, paragraph 2 * * page 52, column 2, paragraphs 1,3,4,6 * * page 53, column 1, paragraph 2 - column 2, paragraph 1 * * page 54, column 2, paragraph 1 - page 55, column 1, paragraph 1 * DOI: http://dx.doi.org/10.1093/intimm/12.1.51 | [Y] - BUONFIGLIO DONATELLA ET AL, "Characterization of a novel human surface molecule selectively expressed by mature thymocytes, activated T cells and subsets of T cell lymphomas.", EUROPEAN JOURNAL OF IMMUNOLOGY, (1999), vol. 29, no. 9, ISSN 0014-2980, pages 2863 - 2874, XP001037424 [Y] 1-4,10-87,91-102 * abstract * * page 2864, column 1, paragraph 2 * * page 2869, column 1, paragraph 2 - column 2, paragraph 1 * DOI: http://dx.doi.org/10.1002/(SICI)1521-4141(199909)29:09<2863::AID-IMMU2863>3.0.CO;2-W | [PY] - TEZUKA KATSUNARI ET AL, "Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (20000916), vol. 276, no. 1, ISSN 0006-291X, pages 335 - 345, XP000999375 [PY] 1-4,10-87,91-102 * abstract * * page 335, column 2, paragraph 4 - page 337, column 1, paragraph 1 * * page 338, column 2, paragraph 2 * * page 340, column 2, paragraph 2 - page 342, column 1, paragraph 1 * * page 343, column 2, paragraph 2 * DOI: http://dx.doi.org/10.1006/bbrc.2000.3466 | [Y] - HUTLOFF A ET AL, "ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, (19990121), vol. 397, ISSN 0028-0836, pages 263 - 266, XP002156736 [Y] 1-4,10-87,91-102 * abstract * * page 263, column 1, paragraph 2 - column 2, paragraph 3 * DOI: http://dx.doi.org/10.1038/16717 | [Y] - SATO TOSHIROU ET AL, "Up-regulation of inducible co-stimulator (ICOS) expression and its regulation of cytokine production in inflammatory bowel disease.", GASTROENTEROLOGY, 101st Annual Meeting of the American Gastroenterological Association and the Digestive Disease Week.;San Diego, California, USA; May 21-24, 2000, (200004), vol. 118, no. 4 Suppl. 2 Part 1, ISSN 0016-5085, page AGA A662, XP001021165 [Y] 1-4,10-87,91-102 * abstract * | [X] - MAGES HANS W ET AL, "Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand.", EUROPEAN JOURNAL OF IMMUNOLOGY, (200004), vol. 30, no. 4, ISSN 0014-2980, pages 1040 - 1047, XP000971268 [X] 104,105 * abstract * * page 1041, column 1, paragraph 1 * * page 1042, column 2, paragraph 3 * * page 1044, column 1, paragraph 1 - column 2, paragraph 1; figure 7 * * page 1046, column 1, paragraph 3 - column 2, paragraph 1 * DOI: http://dx.doi.org/10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6 | by applicant | EP0984023 | - FASEB J., (20000420), vol. 14 |